RTTR - Ritter Pharmaceuticals Inc.

0.448
0.448   100.000%

Share volume: 0
Last Updated: 05-22-2020

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.45
P/E Ratio 
N/A
DAY RANGE
$0.45 - $0.45
EPS 
-$0.61
52 WEEK RANGE
$0.15 - $1.27
52 WEEK CHANGE
-$45.17
MARKET CAP 
20.677 M
YIELD 
N/A
SHARES OUTSTANDING 
46.153 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$45,188,402
AVERAGE 10 VOLUME 
$31,092,736
AVERAGE 30 VOLUME 
$23,045,081
Company detail
CEO: Andrew J. Ritter
Region: US
Website: http://www.ritterpharmaceuticals.com
Employees: 5
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry:
Sector:

Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.

Recent news